share_log

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

正在关注贝勒生物科学;布鲁克林资本重申买入评级,设定19美元的目标股价
Benzinga Real-time News ·  2023/01/05 11:42

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

正在关注贝勒生物科学;布鲁克林资本重申买入评级,设定19美元的目标股价

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发